Daniel Gilmer, PhD, is a Senior Director and Commercial Quality US Team Lead at Pfizer, with 19 years of experience in academic research, management consulting, and healthcare commercialization. They previously served as an Engagement Manager at McKinsey & Company and held various positions at Pfizer, including U.S. PAXLOVID Launch Lead. As an equal co-inventor of Exebacase, they have achieved notable successes in both scientific discovery and commercial excellence. Currently, they are furthering their education at The Rockefeller University while also serving as a Term Member at the Council on Foreign Relations.
This person is not in any teams
This person is not in any offices